Quick Answer
TELA Bio, Inc. reported Shares Outstanding of 44.54 million shares for fiscal year 2025.
TELA Bio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 44.54M | +13.1% |
| 2024 | 39.40M | +60.8% |
| 2023 | 24.49M | +27.8% |
| 2022 | 19.17M | +31.9% |
| 2021 | 14.53M | +0.6% |
| 2020 | 14.44M | +26.6% |
| 2019 | 11.41M | +3757.1% |
| 2018 | 295,717 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 40.34M | +63.2% | +1.9% |
| June 30, 2025 | 39.58M | +60.4% | +0.1% |
| March 31, 2025 | 39.55M | +60.4% | +0.4% |
| December 31, 2024 | 39.40M | +60.8% | +59.4% |
| September 30, 2024 | 24.72M | +0.9% | +0.2% |
| June 30, 2024 | 24.68M | +0.8% | +0.1% |
| March 31, 2024 | 24.65M | +28.2% | +0.7% |
| December 31, 2023 | 24.49M | +27.8% | +0.0% |
- TELA Bio, Inc. showed an increase of +13.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, TELA Bio, Inc.’s shares outstanding has grown by 14961.1% (from 295.7 thousand shares to 44.54 million shares).
- The most recent figure is from TELA Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: